Bright Minds Biosciences Inc. (DRUG)
NASDAQ·Healthcare·Biotechnology
$60.97
-0.98%
Mkt Cap $535.54M
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (5 analysts)
$136.50
Range $126.00 – $147.00
Implied Upside
+123.9%
Consensus $136.50 vs current $60.97